EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
TSX:EXE - Toronto Stock Exchange - CA30224T8639 - Common Stock - Currency: CAD
EXE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. EXE has an excellent profitability rating, but there are some minor concerns on its financial health. EXE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
EXE had positive earnings in the past year.
EXE had a positive operating cash flow in the past year.
EXE had positive earnings in each of the past 5 years.
EXE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 10.81%, EXE belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
EXE has a Return On Equity of 61.61%. This is amongst the best in the industry. EXE outperforms 93.33% of its industry peers.
EXE has a Return On Invested Capital of 20.15%. This is amongst the best in the industry. EXE outperforms 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXE is above the industry average of 8.15%.
The last Return On Invested Capital (20.15%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROIC | 20.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
EXE has a Profit Margin of 5.23%. This is in the better half of the industry: EXE outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of EXE has grown nicely.
With a decent Operating Margin value of 7.91%, EXE is doing good in the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Operating Margin of EXE has grown nicely.
With a Gross Margin value of 14.04%, EXE is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
Compared to 1 year ago, EXE has more shares outstanding
EXE has less shares outstanding than it did 5 years ago.
EXE has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.06 indicates that EXE is not in any danger for bankruptcy at the moment.
EXE has a Altman-Z score of 3.06. This is in the better half of the industry: EXE outperforms 80.00% of its industry peers.
EXE has a debt to FCF ratio of 128.12. This is a negative value and a sign of low solvency as EXE would need 128.12 years to pay back of all of its debts.
The Debt to FCF ratio of EXE (128.12) is comparable to the rest of the industry.
EXE has a Debt/Equity ratio of 2.16. This is a high value indicating a heavy dependency on external financing.
EXE has a worse Debt to Equity ratio (2.16) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Altman-Z | 3.06 |
ROIC/WACC2.95
WACC6.84%
2.3 Liquidity
EXE has a Current Ratio of 0.84. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
EXE has a Current ratio of 0.84. This is comparable to the rest of the industry: EXE outperforms 53.33% of its industry peers.
A Quick Ratio of 0.84 indicates that EXE may have some problems paying its short term obligations.
EXE's Quick ratio of 0.84 is in line compared to the rest of the industry. EXE outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 115.90% over the past year.
Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 9.38% in the last year.
EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.31% yearly.
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
3.2 Future
Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.75% on average per year.
The Revenue is expected to grow by 4.76% on average over the next years.
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.75%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.76%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.07, the valuation of EXE can be described as rather expensive.
EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 86.67% of the companies in the same industry.
EXE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.32.
EXE is valuated correctly with a Price/Forward Earnings ratio of 16.19.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 80.00% of the companies listed in the same industry.
EXE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 16.19 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 86.67% of the companies listed in the same industry.
EXE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 530.47 | ||
| EV/EBITDA | 9.1 |
4.3 Compensation for Growth
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.75
EPS Next 2Y4.74%
EPS Next 3Y7.81%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 3.52%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.21, EXE pays a better dividend. On top of this EXE pays more dividend than 86.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, EXE pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
51.91% of the earnings are spent on dividend by EXE. This is a bit on the high side, but may be sustainable.
The dividend of EXE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.91%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
TSX:EXE (6/17/2025, 7:00:00 PM)
14.17
+0.09 (+0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.58%
Inst Owner ChangeN/A
Ins Owners13.13%
Ins Owner ChangeN/A
Market Cap1.19B
Analysts74
Price Target16.41 (15.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP51.91%
Div Incr Years1
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.88%
PT rev (3m)22.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.07 | ||
| Fwd PE | 16.19 | ||
| P/S | 0.81 | ||
| P/FCF | 530.47 | ||
| P/OCF | 23.63 | ||
| P/B | 9.49 | ||
| P/tB | 197.89 | ||
| EV/EBITDA | 9.1 |
EPS(TTM)0.83
EY5.86%
EPS(NY)0.88
Fwd EY6.18%
FCF(TTM)0.03
FCFY0.19%
OCF(TTM)0.6
OCFY4.23%
SpS17.58
BVpS1.49
TBVpS0.07
PEG (NY)N/A
PEG (5Y)0.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.81% | ||
| ROE | 61.61% | ||
| ROCE | 26.66% | ||
| ROIC | 20.15% | ||
| ROICexc | 26.88% | ||
| ROICexgc | 42.25% | ||
| OM | 7.91% | ||
| PM (TTM) | 5.23% | ||
| GM | 14.04% | ||
| FCFM | 0.15% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexcg growth 3Y72.34%
ROICexcg growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score7
Asset Turnover2.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.16 | ||
| Debt/FCF | 128.12 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 143.57% | ||
| Cap/Sales | 3.26% | ||
| Interest Coverage | 9.47 | ||
| Cash Conversion | 33.51% | ||
| Profit Quality | 2.9% | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 3.06 |
F-Score7
WACC6.84%
ROIC/WACC2.95
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.9%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%27.83%
EPS Next Y-4.22%
EPS Next 2Y4.74%
EPS Next 3Y7.81%
EPS Next 5Y8.75%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%2.06%
Revenue Next Year8.95%
Revenue Next 2Y6.76%
Revenue Next 3Y5.17%
Revenue Next 5Y4.76%
EBIT growth 1Y90.12%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year-5.03%
EBIT Next 3Y4.16%
EBIT Next 5Y2.88%
FCF growth 1Y102.3%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y173.94%
OCF growth 3Y31.32%
OCF growth 5Y26.02%